AMERISAFE Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMERISAFE stock.
View analyst ratings for AMERISAFE or view top-rated stocks.

Wall Street analysts have given AMERISAFE a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AMERISAFE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

AMERISAFE is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for AMERISAFE.

AMERISAFE will be holding an earnings conference call on Thursday, April 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

AMERISAFE, Inc. (NASDAQ:AMSF) posted its quarterly earnings data on Tuesday, February, 23rd. The insurance provider reported $1.22 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.86 by $0.36. The insurance provider had revenue of $82 million for the quarter, compared to analyst estimates of $80.72 million. AMERISAFE had a net margin of 26.84% and a trailing twelve-month return on equity of 20.22%.
View AMERISAFE's earnings history.

AMERISAFE's stock was trading at $60.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AMSF stock has increased by 6.8% and is now trading at $65.16.
View which stocks have been most impacted by COVID-19.

AMERISAFE announced a quarterly dividend on Wednesday, February 24th. Shareholders of record on Friday, March 12th will be given a dividend of $0.29 per share on Friday, March 26th. This represents a $1.16 annualized dividend and a dividend yield of 1.78%. The ex-dividend date is Thursday, March 11th. This is an increase from AMERISAFE's previous quarterly dividend of $0.27.
View AMERISAFE's dividend history.

AMERISAFE pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.81%. AMERISAFE does not yet have a strock track record of dividend growth. The dividend payout ratio of AMERISAFE is 25.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AMERISAFE will have a dividend payout ratio of 39.73% next year. This indicates that AMERISAFE will be able to sustain or increase its dividend.
View AMERISAFE's dividend history.

2 brokers have issued 1 year price objectives for AMERISAFE's shares. Their forecasts range from $72.00 to $72.00. On average, they expect AMERISAFE's share price to reach $72.00 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price.
View analysts' price targets for AMERISAFE or view top-rated stocks among Wall Street analysts.

18 employees have rated AMERISAFE CEO Janelle Frost on Glassdoor.com. Janelle Frost has an approval rating of 79% among AMERISAFE's employees.

Some companies that are related to AMERISAFE include Berkshire Hathaway (BRK.B), The Progressive (PGR), The Travelers Companies (TRV), The Allstate (ALL), Cincinnati Financial (CINF), Markel (MKL), Arch Capital Group (ACGL), W. R. Berkley (WRB), Fidelity National Financial (FNF), CNA Financial (CNA), Erie Indemnity (ERIE), Old Republic International (ORI), First American Financial (FAF), RLI (RLI) and The Hanover Insurance Group (THG).
View all of AMSF's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

AMERISAFE trades on the NASDAQ under the ticker symbol "AMSF."

AMERISAFE's stock is owned by many different retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.07%). Company insiders that own AMERISAFE stock include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, Randy Roach and Vincent J Gagliano.
View institutional ownership trends for AMERISAFE.

AMSF stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold AMERISAFE company stock in the last year include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, and Vincent J Gagliano.
View insider buying and selling activity for AMERISAFE or view top insider-selling stocks.

Shares of AMSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMSF stock can currently be purchased for approximately $65.16.

AMERISAFE has a market capitalization of $1.26 billion and generates $370.37 million in revenue each year. The insurance provider earns $92.69 million in net income (profit) each year or $4.60 on an earnings per share basis.

AMERISAFE employs 393 workers across the globe.

The official website for AMERISAFE is www.amerisafe.com.

AMERISAFE is headquartered at 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634.

AMERISAFE's mailing address is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. The insurance provider can be reached via phone at 337-463-9052 or via email at [email protected]